$MorphoSys(MOR.US)$MorphoSys Spokesperson Says "This Story Is Factually Wrong" In An Emailed Statement To Bloomberg News, In Response To STAT News' Adam Feuerstein Article Entitled, "Why Novartis Is Going To Walk Away From Its Acquisition" Benzinga· 5 mins ago Why Novartis is going to walk from its acquisition of MorphoSys (statnews.com) Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not c...
Palantir's Q4 commercial business performance was 'bombastic, baller, incomprehensibly good', according to CEO Alex Karp. Coherent sees 'improving demand trends', expecting 'ongoing sequential improvement in revenue growth'. Chegg's Q1 guidance disappointed investors. NXP Semiconductors' Q4 results surpassed expectations. Novartis' acquisition of MorphoSys is viewed positively.
Jaguar8 : 格羅爾
Jaguar8 : 即使是虛假新聞在股市上也有很多
Trytosaveabit樓主 Jaguar8: 是的是啊!它無處不在